tiprankstipranks
Oncolytics submits Type C meeting request to FDA
PremiumThe FlyOncolytics submits Type C meeting request to FDA
17d ago
Oncolytics initiated with an Outperform at Raymond James
PremiumThe Fly
Oncolytics initiated with an Outperform at Raymond James
24d ago
Oncolytics Biotech Showcases at Oncology Event
PremiumCompany Announcements
Oncolytics Biotech Showcases at Oncology Event
26d ago
Is ONCY a Buy, Before Earnings?
PremiumPre-EarningsIs ONCY a Buy, Before Earnings?
2M ago
Oncolytics Biotech Reveals Upcoming Financial Call
PremiumCompany Announcements
Oncolytics Biotech Reveals Upcoming Financial Call
2M ago
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
PremiumPress Releases
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
2M ago
Oncolytics price target lowered to $5 from $15 at H.C. Wainwright
PremiumThe FlyOncolytics price target lowered to $5 from $15 at H.C. Wainwright
6M ago
Oncolytics reports ‘positive’ interim results from Phase 1/2 GOBLET study
PremiumThe Fly
Oncolytics reports ‘positive’ interim results from Phase 1/2 GOBLET study
6M ago
Oncolytics provides update on pancreatic cancer program for pelareorep
PremiumThe Fly
Oncolytics provides update on pancreatic cancer program for pelareorep
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100